Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -9.54% vs 2.33% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -7.37% vs -6.59% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -14.21% vs 1.36% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Zhejiang Haisen Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -38.18% vs 50.13% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -9.54% vs 2.33% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -39.41% vs 74.09% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -7.37% vs -6.59% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -42.45% vs 53.59% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -14.21% vs 1.36% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






